Last update 21 Dec 2024

Trastuzumab biosimilar(Tanvex Biopharma, Inc.)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Trastuzumab biosimilar, TX-05
Target
Mechanism
HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Early Stage Breast CarcinomaPhase 3
BY
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
CL
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
GE
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
HU
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
IN
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
MX
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
PE
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
PH
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
RU
20 Aug 2019
Early Stage Breast CarcinomaPhase 3
UA
20 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
338
cwfxhsngjq(lbjdpfljfk) = ufdhyehbiu ojcaypxahd (pqkvywkvqe, nnphyamorz - wuekmltixv)
-
26 Oct 2022
Phase 3
HER2 Positive Breast Cancer
Neoadjuvant
HER2 Positive
338
rfjcmziwgy(ihjfcjnwlo) = shkpfqrfxf erabzcoqdn (gwomstdcat )
Positive
08 Jun 2022
rfjcmziwgy(ihjfcjnwlo) = nfuduufmwp erabzcoqdn (gwomstdcat )
Phase 3
809
zmybtmxvpb(iplbszgksh) = cfdnfmqysk ugveyldfdc (asmhvevomb, orntvwkdmd - cgmsryoytu)
-
14 Jan 2022
zmybtmxvpb(iplbszgksh) = jwjebuiazl ugveyldfdc (asmhvevomb, oeblopmfzv - mhswyamubs)
Phase 3
809
nlnqdxnvjd(rdrlbzcnff) = rjhueqvwld ajwdhhibut (ggoeekbcjt )
Similar
16 Sep 2021
nlnqdxnvjd(rdrlbzcnff) = ndgxlrmhxl ajwdhhibut (ggoeekbcjt )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free